Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 273 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q1
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Health Issues
View →
Q1
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
1T
TWENTY-FIRST CENTURY GROUP, INC. for RAFAEL HOLDINGS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $24,000.00 income
Health Issues
View →
2A
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid
View →
3A
NOVARTIS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
2A
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
4A
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate
Medical/Disease Research/Clinical Labs, Tobacco, Health Issues, Medicare/Medicaid
View →
Q4
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy, Taxation/Internal Revenue Code
View →
Q4
NATIONWIDE CHILDREN'S HOSPITAL, INC. for NATIONWIDE CHILDREN'S HOSPITAL INC
4th Quarter (Oct 1 - Dec 31) 2025 · Ohio · House · Senate
Health Issues, Medicare/Medicaid
View →
Q4
YC CONSULTING, LLC for PATIENTS RISING NOW
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q4
THE VOGEL GROUP for FORTRESS BIOTECH INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Florida · House · Senate · $20,000.00 income
Health Issues
View →
Q4
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate
Health Issues, Insurance, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q4
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills)
View →
Q4
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q4
SPLITOAK STRATEGIES LLC for CHIESI USA, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · North Carolina · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q4
ALLIANCE FOR REGENERATIVE MEDICINE for ALLIANCE FOR REGENERATIVE MEDICINE
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q4
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $80,000.00 income
Taxation/Internal Revenue Code, Medicare/Medicaid, Pharmacy, Health Issues
View →
Q4
BLUE CROSS BLUE SHIELD OF MICHIGAN for BLUE CROSS BLUE SHIELD OF MICHIGAN
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
EPILEPSY FOUNDATION for EPILEPSY FOUNDATION
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate
Budget/Appropriations, Health Issues, Civil Rights/Civil Liberties, Education
View →
Q4
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View →
Q4
NOVARTIS for NOVARTIS
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues
View →
Q4
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid
View →
Q4
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Agriculture, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
Q4
THE MCMANUS GROUP for FULCRUM THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Health Issues
View →
Q4
NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES for NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Defense, Budget/Appropriations
View →
Previous Page 4 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem